The International Society of Cardiovascular Pharmacotherapy (ISCP) was created to support and promote ethical, evidence-based, cardiovascular pharmacotherapy worldwide. ISCP represents an ideal forum for open discussions on all issues related to cardiovascular pharmacotherapy and the society endeavours to foster collaboration among health professionals around the World. ISCP promotes education, research, and best clinical practice regarding the pharmacological treatment of cardiovascular conditions. ISCP ultimately aims to prevent cardiovascular disease where possible and improve patient well being through the pharmacological treatment of cardiac conditions. ISCP is a member of the World Heart Federation and currently has representatives –ISCP Governors– from over 45 countries around the World.

For more information, visit ISCP website.

ISCP EXECUTIVE COMMITTEE